I am founder of the Cancer Innovation and Regulation Initiative and serve on the European Society for Medical Oncology (ESMO) Clinical Benefit Scale Committee. Previously, I was a Visiting Expert at the European Medicines Agency and a member of a US Food and Drug Administration working group on molecular targets for pediatric cancers.
My work focuses on new medicines and digital health in the US and Europe. I have published over 80 peer-reviewed papers, including in Science, JAMA, and the New England Journal of Medicine. I received my undergraduate and medical degrees (summa cum laude) from Harvard and completing my training in urological surgery and urologic oncology at Harvard/BWH and Dana-Farber Cancer Institute.
Laboratory for Technology, Markets, and Regulation \ Lab. für Technologie und MarktregulierungThe Laboratory for Technology, Markets, and Regulation examines access to technologies transforming our society and our health. Our team is advising international, federal, and state governments on ways to modernize regulatory and payment systems.